1. Home
  2. OTLK vs RELL Comparison

OTLK vs RELL Comparison

Compare OTLK & RELL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Outlook Therapeutics Inc.

OTLK

Outlook Therapeutics Inc.

HOLD

Current Price

$0.52

Market Cap

249.6M

Sector

Health Care

ML Signal

HOLD

Logo Richardson Electronics Ltd.

RELL

Richardson Electronics Ltd.

HOLD

Current Price

$17.80

Market Cap

248.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
OTLK
RELL
Founded
2010
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Electronic Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
249.6M
248.1M
IPO Year
2016
2004

Fundamental Metrics

Financial Performance
Metric
OTLK
RELL
Price
$0.52
$17.80
Analyst Decision
Buy
Analyst Count
4
0
Target Price
$5.03
★ $25.50
AVG Volume (30 Days)
★ 3.8M
312.3K
Earning Date
08-14-2026
10-07-2026
Dividend Yield
N/A
★ 1.37%
EPS Growth
★ 55.91
N/A
EPS
N/A
★ N/A
Revenue
$8,146,123.00
★ $228,564,000.00
Revenue This Year
N/A
$12.68
Revenue Next Year
$6,355.64
$9.21
P/E Ratio
★ N/A
$230.96
Revenue Growth
N/A
★ 9.41
52 Week Low
$0.16
$9.37
52 Week High
$2.54
$23.15

Technical Indicators

Market Signals
Indicator
OTLK
RELL
Relative Strength Index (RSI) 40.37 44.68
Support Level $0.40 $15.83
Resistance Level $0.72 $18.81
Average True Range (ATR) 0.05 1.22
MACD 0.01 -0.26
Stochastic Oscillator 50.19 14.93

Price Performance

Historical Comparison
OTLK
RELL

About OTLK Outlook Therapeutics Inc.

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA, which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.

About RELL Richardson Electronics Ltd.

Richardson Electronics Ltd is a world-wide manufacturer of engineered solutions, green energy products, power grid and microwave tubes, and related consumables; power conversion and RF and microwave components including green energy solutions; tubes for diagnostic imaging equipment; and customized display solutions. It serve customers in alternative energy, healthcare, aviation, broadcast, communications, industrial, marine, medical, military, scientific, and semiconductor markets. Its products and services include design-in support, systems integration, prototype design and manufacturing, testing, logistics, etc. Its segments are Power and Microwave Technologies (PMT), Green Energy Solutions (GES), and Canvys. Majority of Sales is from PMT. Majority of sales is from North America.

Share on Social Networks: